Hypercapnia and Its Association With Long-term Respiratory Morbidities in Premature Infants With Chronic Lung Disease
NCT02996162 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2021-08-02
Summary
This is a prospective, longitudinal observational study to provide data regarding the natural course of hypercapnia in premature infants with bronchopulmonary dysplasia using both available blood pCO2 and measured capnography, as well as relate the degree and trend of hypercapnia to later respiratory outcomes.
Conditions
- Bronchopulmonary Dysplasia
Interventions
- DEVICE
-
Massimo Root Monitoring System
The Masimo Root system is a patient monitoring and connectivity platform; Root displays patient monitoring information from the connected modules. This will be used as a non-invasive way to determine infants' pCO2. The equipment will be used in the inpatient portion of the study up to twice weekly for 5 minutes to obtain approximately 150 end tidal CO2 values and recorded over time for each infant. In the outpatient portion, it will be used in each clinic visit in a similar fashion.
- DEVICE
-
ISA-Infrared Sidestream Gas Analyzer
The ISA-Infrared Sidestream Gas Analyzer displays end-tidal carbon dioxide waveforms and measurements and trends of end tidal CO2. This will be used as a non-invasive way to determine infants' pCO2. The equipment will be used in the inpatient portion of the study up to twice weekly for 5 minutes to obtain approximately 150 end tidal CO2 values and recorded over time for each infant. In the outpatient portion, it will be used in each clinic visit in a similar fashion.
Sponsors & Collaborators
-
Beth Israel Deaconess Medical Center
collaborator OTHER - lead OTHER
Principal Investigators
-
Kristen Leeman, MD · Boston Children's Hospital
Eligibility
- Min Age
- 3 Days
- Max Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-01
- Primary Completion
- 2021-05-06
- Completion
- 2021-05-06
Countries
- United States
Study Locations
More Related Trials
-
Measurement of Expiratory Flow Variability for the Detection of Bronchospasm in Infants Using the Ventica® Device by Revenio
NCT04702620 ·Status: UNKNOWN
-
The Evaluation of a Noninvasive Respiratory Monitor in Pediatric Patients Undergoing General Anesthesia
NCT02336022 ·Status: COMPLETED
-
Integrated Pulmonary Index (IPI) as a Determinate of Weaning Success and/or Failure in the Pediatric Population
NCT01795196 ·Status: WITHDRAWN
-
Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease
NCT05285345 ·Status: RECRUITING
-
Preterm Lung Patient Registry
NCT00951366 ·Status: RECRUITING
-
Nasal High Frequency Ventilation in Preterm Infants: A Pilot Study
NCT00296231 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age
NCT04264156 ·Status: TERMINATED ·Phase: PHASE2
-
Oxygen Saturation Monitoring in Bronchiolitis
NCT02947204 ·Status: COMPLETED ·Phase: NA
-
Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia
NCT01503801 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies
NCT00551642 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Cohort Study of Distribution of Ventilation in Pediatrics Requiring Mechanical Ventilation by Electrical Impedance Tomography
NCT02247700 ·Status: COMPLETED
-
Inhaled Beclomethasone to Prevent Chronic Lung Disease
NCT00000576 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Synchronized vs. Continuous HFNC Using NAVA on WOB in Infants With BPD
NCT04274192 ·Status: TERMINATED ·Phase: NA
-
Neonatal Intensive Care (NICU) Course and Hospital Outcome of Infants With BPD Treated Using Inhaled Nitric Oxide
NCT00757146 ·Status: COMPLETED
-
Structured Light Plethysmography in Obstructive Airways Disease
NCT03499938 ·Status: COMPLETED
-
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
NCT00006401 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
NCT01035190 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants.
NCT01268215 ·Status: UNKNOWN ·Phase: PHASE2
-
Inhaled Budesonide for Non-ventilated Infants at High Risk of Bronchopulmonary Dysplasia: the i-BUD Pilot Study
NCT01895075 ·Status: WITHDRAWN ·Phase: PHASE2
-
Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants
NCT00931632 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of Flow Rate Change on CO2 Levels During High Flow Nasal Ventilation (HFNV) in Preterm Infants.
NCT06622902 ·Status: RECRUITING ·Phase: NA
-
Study of the Effects of CPAP and HHHFNC on Diaphragmatic Dimensions in Preterm Infants
NCT02421328 ·Status: COMPLETED ·Phase: NA
-
Impact of Respiratory Pathogens in Infants
NCT01789268 ·Status: COMPLETED
-
Bedside Lung Ultrasound in Young Children Presenting to the Emergency Department (ED) With Wheezing
NCT01452945 ·Status: COMPLETED
-
Aerosolized Albuterol Use in Severe BPD
NCT02766673 ·Status: COMPLETED ·Phase: NA